168 related articles for article (PubMed ID: 37082169)
1. Lambert-Eaton myasthenic syndrome with primary thymic marginal zone B-cell lymphoma: A case report.
Soma T; Matsumoto A; Shoji T; Katakura H
Respirol Case Rep; 2023 May; 11(5):e01149. PubMed ID: 37082169
[TBL] [Abstract][Full Text] [Related]
2. Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case report.
Zhang RR; Han T; Guo F; Liu ZZ; Han YL; Chen WC; Liu YY; Xie XD
Oncol Lett; 2015 Sep; 10(3):1339-1342. PubMed ID: 26622673
[TBL] [Abstract][Full Text] [Related]
3. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
4. Thymic Small Cell Carcinoma Associated With Lambert-Eaton Myasthenic Syndrome.
Hashimoto S; Hayasaka K; Suzuki K; Endoh M; Yanagawa N; Shiono S
Ann Thorac Surg; 2020 May; 109(5):e347-e348. PubMed ID: 31586614
[TBL] [Abstract][Full Text] [Related]
5. Lambert-Eaton myasthenic syndrome with anti-acetylcholine receptor antibody and anterior mediastinal tumor.
Matsumoto H; Ohtomo G; Akahori T; Hashida H
J Gen Fam Med; 2017 Oct; 18(5):282-284. PubMed ID: 29264043
[TBL] [Abstract][Full Text] [Related]
6. [Lambert-Eaton myasthenic syndrome--a rare manifestation of paraneoplastic syndrome in ovarian cancer--case report].
Zivaljević M; Popović S; Vujkov T
Med Pregl; 2005; 58(9-10):495-7. PubMed ID: 16526254
[TBL] [Abstract][Full Text] [Related]
7. [Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].
Boutin E; Rey C; Romeu M; Pouget J; Franques J
Rev Med Interne; 2013 Aug; 34(8):493-6. PubMed ID: 23759215
[TBL] [Abstract][Full Text] [Related]
8. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
9. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Lambert-Eaton Myasthenia Syndrome Associated with Non-Hodgkin's Lymphoma: A Case Report and Review of the Literature.
Abu-Tineh M; Alamin MA; Aljaloudi E; Alshurafa A; Garcia-Cañibano B; Taha RY; Elkourashy SA
Case Rep Oncol; 2023; 16(1):1300-1305. PubMed ID: 37942405
[TBL] [Abstract][Full Text] [Related]
11. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis Lambert-Eaton overlap syndrome.
Oh SJ
Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
[TBL] [Abstract][Full Text] [Related]
13. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
14. Unusual paraneoplastic syndromes in pancreatic cancer: a case report of Lambert-Eaton myasthenic syndrome (LEMS) associated with intraductal papillary mucinous cancer of the pancreas.
Zamparas A; Herzog T; Förster S; Siglienti I; Uhl W; Strotmann J; Höhn P
AME Case Rep; 2023; 7():35. PubMed ID: 37942046
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment.
Pascuzzi RM; Bodkin CL
Neuropsychiatr Dis Treat; 2022; 18():3001-3022. PubMed ID: 36578903
[TBL] [Abstract][Full Text] [Related]
16. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
[TBL] [Abstract][Full Text] [Related]
17. [Resected thymic hyperplasia with myasthenia gravis and Lambert-Eaton myasthenic syndrome].
Mitomo H; Tabata T; Sugawara T; Miyamoto A; Fujimura S; Murakami K
Kyobu Geka; 2014 Mar; 67(3):194-7. PubMed ID: 24743528
[TBL] [Abstract][Full Text] [Related]
18. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome.
Wirtz PW; Sotodeh M; Nijnuis M; Van Doorn PA; Van Engelen BG; Hintzen RQ; De Kort PL; Kuks JB; Twijnstra A; De Visser M; Visser LH; Wokke JH; Wintzen AR; Verschuuren JJ
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):766-8. PubMed ID: 12438488
[TBL] [Abstract][Full Text] [Related]
19. Lambert-Eaton syndrome, an unrecognized treatable pediatric neuromuscular disorder: three patients and literature review.
Hajjar M; Markowitz J; Darras BT; Kissel JT; Srinivasan J; Jones HR
Pediatr Neurol; 2014 Jan; 50(1):11-7. PubMed ID: 24138947
[TBL] [Abstract][Full Text] [Related]
20. Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
Bodkin C; Pascuzzi RM
Neurol Clin; 2021 Feb; 39(1):133-146. PubMed ID: 33223079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
